3D In vitro contract research services
Why
3D in vitro ?
With the change in regulations that no longer require animal testing models as compulsory, there is a growing anticipation of 2D/3D models as an alternative for drug testing.
Our service offers a great solution that respects animal welfare and experiment ethics while providing a competitive advantage for clients in drug development.
By utilizing our CRO 3D in-vitro activity testing and CubiX microphysiological system, clients can achieve greater accuracy and precision without the need for animal testing. With a focus on moral values and innovation, our service offers a more ethical and efficient approach to drug development.
![Cherry Biotech 3D invitro CRO service](https://www.cherrybiotech.com/wp-content/uploads/2023/06/Cherry-Biotech-3D-invitro-CRO-service.png)
service highlights
Our CRO service provides standard and custom in vitro studies using organ-on-a-well (OOW) technology to support drug development.
Our service highlights:
Human-relevant 3D in vitro models
Access to OOW technology without investing in equipment
Time saving & cost-effective results
Cutting-edge expertise in Organ-on-Well technology
Proven track record for delivering clinically translatable results
related resources
Multiorgan Microphysiological Systems as
Introduction MPS (Multiorgan Microphysiological Systems) have evolved from tools to reduce animal...
Read MoreMelanoma Immunotherapy and Precision
Introduction Melanoma is clearly a complex disease with a high degree of...
Read MoreMicrofluidic organ-on-chip system for
Introduction The researchers created a microfluidic organ-on-chip solution with integrated electrochemical microsensor arrays enabling...
Read MoreThey trust Us
![Inside Therapeutics-Lipid nanoparticle manufacturing partner](https://www.cherrybiotech.com/wp-content/uploads/2023/11/Inside-Therapeutics-Lipid-nanoparticle-manufacturing-partner.png)
![Quimivita](https://www.cherrybiotech.com/wp-content/uploads/2023/06/Quimivita.jpg)
![VuMC](https://www.cherrybiotech.com/wp-content/uploads/2023/06/VuMC.jpg)
![Elvesys](https://www.cherrybiotech.com/wp-content/uploads/2023/06/Elvesys-2.jpg)
![4Dcell](https://www.cherrybiotech.com/wp-content/uploads/2023/06/4Dcell.jpg)
![Biosense](https://www.cherrybiotech.com/wp-content/uploads/2023/06/Biosense.jpg)
![CRG](https://www.cherrybiotech.com/wp-content/uploads/2023/06/CRG.jpg)
![Groupe-ICARE](https://www.cherrybiotech.com/wp-content/uploads/2023/06/Groupe-ICARE.jpg)
![IDIBAPS](https://www.cherrybiotech.com/wp-content/uploads/2023/06/IDIBAPS.jpg)
![IGDR](https://www.cherrybiotech.com/wp-content/uploads/2023/06/IGDR.jpg)
![IRSET](https://www.cherrybiotech.com/wp-content/uploads/2023/06/IRSET.jpg)
![ICFO logo](https://www.cherrybiotech.com/wp-content/uploads/2023/08/ICFO-logo.png)
![logo_PSCC](https://www.cherrybiotech.com/wp-content/uploads/2024/01/logo_PSCC.png)
custom your service
For your preclinical tox-efficacy studies,
let our expertise in immune competent vascularized human organ models be at your service